NCT00016991View on ClinicalTrials.gov

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 2001

Study Completion Date

April 30, 2005

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

gefitinib

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER